11 studies recruit in and from this area

IMPORTANT INFOMATION

NON INVASIVE RESEARCH ( Where No Medications or invasive procedures are involved, ie. needles ) there is no need for medical checks.

As a general rule of thumb you will learn about the reimbursements for your time and incovenience at the point of contact with the clinic or at the point of NOTES FOR VOLUNTEERS which BioTrax will continue to upload on certain studies but only where complicated explanations may not be required unless ethics allow in certain circumstances the printing of the financial rewards in relation to geographical conditions, circumstances etc

WHEN APPLYING FOR REAL TIME STUDIES, APPLY FIRST AND CONTACT SECOND.

The Hotline Number will be shown after application in most cases, or where clinics have their own volunteer sites, a link may be provided and all details will be supplied.

PLEASE READ ALL STUDIES CAREFULLY BEFORE APPLICATION TO MAKE SURE YOU DO NOT WASTE YOUR TIME AND EVERYBODY ELSES

NEW TO BIOTRAX VOLUNTEERS:

1) EMAIL A YOU TUBE TO FRIENDS AT THE TOP OF ALL STUDY LISTINGS - ANOTHER BIOTRAX WORLD FIRST
2) EMAIL CLINIC PROFILE PAGES TO UP TO 3 FRIENDS WHERE APPLICABLE
3) ALSO EMAIL PARTICULAR STUDIES BOXES COMPLETE WITH YOU TUBE FOR UP TO 3 FRIENDS.
4) COMPLETLY FREE FILM & TV EXTRAS SECTION US WIDE - SEE STUDIES ON THE MENU BAR - FOLLOW THE STEPS THROUGH
5) MYSTERY SHOPPING HAS FULL PUBLIC ACCESS THROUGHOUT THE US. SEE STUDIES ON THE MENU BAR - FOLLOW THE STEPS THROUGH

HAPPY DAYS - WELL WISHES - BIOTRAX - THE RESEARCH VOLUNTEER SUPPORT GROUP - YOUR ONE STOP SHOP

Study 1277 :ARE YOU SUFFERING FROM DRUG-INDUCED TARDIVE DYSKINESIA - Houston only Texas
Type of Study	Interventional
Aim of Study	Have you ever taken an anti-psychotic medication or Reglan and developed uncontrolled muscle movements? You may qualify for a research study at Baylor College of Medicine.
Inclusion Criteria	You must be between 18 and 75 years of age and have uncontrolled muscle movements for at least 3 months.
Exclusion Criteria	Should not less than 18 years
Area	Houston TX
Duration	Not Given
Reimbursement	Will be compensate for time and travel
Free Gift	Not Given
Other Info	Study Id :1745
Notes	we need participants from Houston only

Study 481 :Need healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD New York
Type of Study	We are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time.
Aim of Study	Need healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD Therapeutic Area: Psychiatry/Psychology Medical Condition(s): Healthy control subjects
Inclusion Criteria	We are looking for subjects who: • Are medically healthy • Have not been treated for a psychological condition in the past or current • Are not taking any medications • Are 18-55 years of age
Exclusion Criteria	The following subjects will be excluded from the study: • Pregnant or nursing • Subjects with an unstable medical condition or illness • Subjects currently taking recreational drugs or abusing alcohol
Area	New York
Duration	n/a
Reimbursement	Eligible participants will receive compensation for their time.
Notes	Center Contact Information Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU Contact Name: Jordan Seidel Title: Research Coordinator

Study 480 :Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia New York
Type of Study	We are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time.
Aim of Study	Urgently Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia Therapeutic Area: Psychiatry/Psychology Medical Condition(s): Healthy control subjects
Inclusion Criteria	We are looking for subjects who: • Are medically healthy • Have not been treated for a psychological condition in the past or current • Are not taking any medications • Are 18-55 years of age
Exclusion Criteria	The following subjects will be excluded from the study: • Pregnant or nursing • Subjects with an unstable medical condition or illness • Subjects currently taking recreational drugs or abusing alcohol
Area	New York
Duration	n/a
Reimbursement	Eligible participants will receive compensation for their time.
Notes	Center Contact Information Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU Contact Name: Jordan Seidel Title: Research Coordinator

Study 560 :Functional Brain Imaging in PTSD New York
Type of Study	Psychiatry/Psychology We are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment.
Aim of Study	Posttraumatic Stress Disorder
Inclusion Criteria	We are looking for subjects who: • Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat) • Are not taking any psychiatric medications • Are 18-55 years of age
Exclusion Criteria	The following subjects will be excluded from the study: • Pregnant or nursing • Subjects with an unstable medical condition or illness • Subjects currently taking recreational drugs or abusing alcohol
Area	New York
Duration	not given
Reimbursement	please contact us so we can discuss further
Other Info	Contact Name: Jordan Seidel Title: Research Coordinator Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States

Study 1157 :Kappa Opiate Receptor Imaging in PTSD New York
Type of Study	Therapeutic Area: Psychiatry/Psychology Medical Condition(s): Posttraumatic Stress Disorder
Aim of Study	We are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment.
Inclusion Criteria	We are looking for subjects who: • Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat) • Are not taking any psychiatric medications • Are 18-55 years of age
Exclusion Criteria	The following subjects will be excluded from the study: • Pregnant or nursing • Subjects with an unstable medical condition or illness (besides depression) • Subjects currently taking recreational drugs or abusing alcohol
Area	New York, NYC
Duration	not given
Reimbursement	please contact us to discuss further.
Other Info	Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU Contact Name:Jordan Seidel Title:Research Coordinator Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States

Study 490 :Need participants suffering from depression in New York - KOR Depression New York
Type of Study	We are looking for participants suffering from depression who are NOT currently taking medication. Eligible participants will receive compensation for their time.
Aim of Study	Urgently need participants suffering from depression in New York - KOR Depression Therapeutic Area: Psychiatry/Psychology Medical Condition(s): Depression
Inclusion Criteria	We are looking for subjects who: • Are experiencing symptoms of depression and anxiety • Are not taking any psychiatric medications • Are 18-55 years of age
Exclusion Criteria	The following subjects will be excluded from the study: • Pregnant or nursing • Subjects with an unstable medical condition or illness (besides depression) • Subjects currently taking recreational drugs or abusing alcohol
Area	New York
Duration	N/a
Reimbursement	Eligible participants will receive compensation for their time.
Other Info	Study Number: S14-00643
Notes	Center Contact Information Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU Contact Name: Jordan Seidel Title: Research Coordinator

Study 1278 :Get $1,575 - STUDY TO ASSESS EFFECTS OF PF-04457845 ON BOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD New York
Type of Study	BOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD
Aim of Study	PF-04457845 is a fatty acid amide hydrolase (FAAH) inhibitor. FAAH is responsible for hydrolyzing the fatty acid amide, anandamide (AEA). Stress induces increases in FAAH activity which result in decreased brain levels of the endocannabinoid (eCB), AEA and reduced signaling via cannabinoid type 1 receptors (CB1). Deficits in eCB signaling may play a key role in the etiology of PTSD and may mediate important components of the PTSD phenotype. Our hypothesis is that the increase in brain AEA levels achieved by inhibition of FAAH will restore signaling through CB1 in a regionally specific manner and thus alleviate the effects of stress.
Inclusion Criteria	1. Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. 2. Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. 3. Male and female subjects of childbearing potential and at risk for pregnancy must agree to use of a highly effective method of contraception throughout the study and for at least the 28 days after the last dose of assigned treatment. 4. Female subjects of non-childbearing potential must meet at least one of the following criteria: a. Have undergone a documented hysterectomy and/or bilateral oophorectomy. b. Have medically confirmed ovarian failure. c. Achieved postmenopausal status, defined as follows: cessation of regular menses for at least 12 consecutive months with no alternative pathological or physiological cause; status may be confirmed by having a serum follicle-stimulating hormone (FSH) level within the laboratory’s reference range for postmenopausal women. All other female subjects (including females with tubal ligations and females that do NOT have a documented hysterectomy, bilateral oophorectomy and/or ovarian failure) will be considered to be of childbearing potential. 5. Healthy male and/or female subjects between the ages of 18 and 60 years, inclusive. Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12-lead ECG and clinical laboratory tests. 6. Body Mass Index (BMI) of 17.5 to 32 kg/m2; and a total body weight _50 kg (110 lbs). 7. Subjects who are right handed. 8. Subjects who can read, speak, and comprehend English. 9. Subjects must be outpatients with a primary diagnosis of PTSD (DSM-V criteria 309.81). Symptom severity must be such that subjects have a Clinician-administered CAPS (_35) and CGI-S score (_3) at both Screening and Day 1 (baseline) visits to qualify for clinical trial entry. PTSD must be the primary psychiatric disorder present (confirmed by Structured Clinical Interview for DSM IV research version patient edition (SCID-RV/P) and the condition that motivated the subject to seek treatment. Subjects with concurrent diagnoses of MDD, which is no more than moderate in severity, dysthymic disorder, generalized anxiety disorder, specific phobia, or social phobia, are eligible, if PTSD is the primary diagnosis and the subject is not currently requiring psychopharmacological intervention for these conditions.
Exclusion Criteria	Who do not match above requirments
Area	New York
Duration	28 days
Reimbursement	Subjects will receive $1,575 for being in this study.
Other Info	Study Coordinator: Jordan Seidel, MA; Jordan.Seidel@nyumc.org; 646-754-4829